IMPORTANT - PATIENTS PLEASE READ: Keep in mind the knowledge and evidence for the thoughts and statements in this website are presented in good faith and are as up-to-date as possible, however it can only be completely so on the day of publication. New knowledge is always arriving so everyone is encouraged to look at other reputable sources of information, as well as here. Only your Eye Care Professional can decide if a particular product, service or treatment is appropriate for you, if you decide that person to be one of us we would be extremly pleased to help. Whoever you choose all users of this website are strongly advised to read the Disclaimer before continuing.
LATEST NEWS! This column will carry the latest news for ADP-EyeCare patients and/or prospective patients.
18/05/2025: On May 15, 2025, Contamac Solutions, Inc. announced a voluntary product recall in the United States for lots HFH, HGC, HGI, HGN, HKF, HKK of Nutrifill, a preservative-free contact lens insertion solution. Go to https://contamacsolutions.com/pages/public-notice-recallto read more.
13/05/2025:Device safety information and medicines recall/notification. Class 4 Medicines Notification, Chemidex Pharma Ltd, Various Products, EL(25)A/21. Page summary: Chemidex Pharma Ltd has informed the MHRA that the Patient Information Leaflet (PIL) in their topical steroid products does not contain all the required safety information. Cartons for the products/batches listed are missing side effect information related to Visual Disturbances.
13/05/2025: 75,000+ Cases of Eye Care Products Recalled Nationwide (USA) Over Sterility Concerns, FDA Says. Go to Healthto read more.
08/05/2025:Company initiated and FDA Enforcement recall of 34,000 contact lenses in February/March 2025. Lens names that may be known to UK ECPs and patients are 'MyDay Toric' and 'Specsavers Easyvision Linarial Toric'. See The Healthyand FDA Enforcement Report.
02/05/2025:Another testmonial added to the ADP Portfolio
23/04/2025: Andrew D Price - Contributing CPD Author to 'Optician' Journal.
24/12/2024:Recall Alert- "FOR IMMEDIATE RELEASE – 12/21/2024 – Fort Worth, Texas. Alcon Laboratories is voluntarily recalling one (1) lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count (Lot 10101) to the consumer level. Alcon evaluated a consumer complaint of foreign material observed inside a sealed single use vial and determined the material to be fungal in nature". Go to Company Announcementfor further information.
15/11/2024: Beth Ralph now 'Holder of Omnigen Amniotic Membrane Training Certificate'.
07/11/2024: Warning.US FDA publish warning letterto 'Fancy Drops Beauty LLC' regarding colour changing eye drops readily available via UK internet supply.
27/09/2024:Recall Alert - The Healthy Magazine reports - "The major pharmaceutical company Allergan, owned by AbbVie, has issued a recall of two eye ointments under the Refresh brand that are targeted to treat dry eye".
This article was originally published in Eye News (www.eyenews.uk.com) and The PMFA Journal (www.thepmfajournal.com) in October 2020 and has been reproduced with the permission of the publisher.
In health our eyelashes protect the eyes, but in disease they can disfigure, impair quality of life and threaten vision. In this review the authors discuss aspects of lashes that are relevant to all professionals working near the eyes and how to keep you and your patients safe.
Longer, darker lashes are having a moment. For those avoiding the risk or expense of lash extensions, serums can seem like a safer, more affordable option. But not all lash serums are created equal – and some come with hidden side-effects.
The key difference lies in the ingredients. Some lash serums use conditioning agents like peptides or plant oils, while others contain powerful pharmaceutical ingredients originally developed for treating eye disease.
I wrote this in Part 1 with a warning we, in the UK, are not imune! - For a many months now I have been aware that when it comes to over the counter (OTC) dry eye drops in the USA things were not quite as benign as one would expect, storms have been blowing across the landscape, primarily associated with a perceived relaxed approach to regulatory over-sight of eye drop safety and claimed health benefits, this has involved more than a handful of products and manufacturers.
Rather like Pandora’s box, upon looking into the huge range of dry eye drops available it has proved to be source of great and unexpected troubles. The afore mentioned perception by some manufacturing and distributing companies has sought to exploit weaknesses in the system of consumer protection in regards to safety and, exaggerated, if not completely false, medical claims.
To continue with my meteorological analogy, just as our prevailing weather systems move from west to east, we in the UK are not completely sheltered from short-cuts in manufacture and distribution in the global supply that have manifested themselves across the pond. Read more to see regrettably how I was correct.
For a many months now I have been aware that when it comes to over the counter (OTC) dry eye drops in the USA things were not quite as benign as one would expect, storms have been blowing across the landscape, primarily associated with a perceived relaxed approach to regulatory over-sight of eye drop safety and claimed health benefits, this has involved more than a handful of products and manufacturers.
Rather like Pandora’s box, upon looking into the huge range of dry eye drops available it has proved to be source of great and unexpected troubles. The afore mentioned perception by some manufacturing and distributing companies has sought to exploit weaknesses in the system of consumer protection in regards to safety and, exaggerated, if not completely false, medical claims.
To continue with my meteorological analogy, just as our prevailing weather systems move from west to east, we in the UK are not completely sheltered from short-cuts in manufacture and distribution in the global supply that have manifested themselves across the pond.
This was spotted by This email address is being protected from spambots. You need JavaScript enabled to view it. he, myself and Beth Ralph of Chesterfield thought it worth republishing. From an orirginal postiong by Marie Homa-Palladino, OD.
I thought I should look again and update these contact lens reminders, especially in view of very distrurbing developments related to counterfeit, contaminated and unsafe products that are more available. They will contribute to the safe and successful continuing wear of these prescribed medical devices.
I thought I should look again and update these contact lens reminders, especially in view of very distrurbing developments related to counterfeit, contaminated and unsafe products that are more available. They will contribute to the safe and successful continuing wear of these prescribed medical devices.
